These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

480 related articles for article (PubMed ID: 2040794)

  • 1. The influence of avidity on signaling murine B lymphocytes with monoclonal anti-IgM antibodies. Effects of B cell proliferation versus growth inhibition (tolerance) of an immature B cell lymphoma.
    Udhayakumar V; Kumar L; Subbarao B
    J Immunol; 1991 Jun; 146(12):4120-9. PubMed ID: 2040794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro and in vivo B lymphocyte-activating properties of monoclonal anti-delta antibodies. I. Determinants of B lymphocyte-activating properties.
    Goroff DK; Stall A; Mond JJ; Finkelman FD
    J Immunol; 1986 Apr; 136(7):2382-92. PubMed ID: 2419432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The synergistic effects of anti-IgM and monoclonal anti-Ia antibodies in induction of murine B lymphocyte activation.
    Baluyut AR; Subbarao B
    J Mol Cell Immunol; 1988; 4(1):45-57. PubMed ID: 3266924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of human B cells and inhibition of their terminal differentiation by monoclonal anti-mu antibodies.
    Maruyama S; Kubagawa H; Cooper MD
    J Immunol; 1985 Jul; 135(1):192-9. PubMed ID: 3923101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of anti-IgM and growth factor-induced proliferation of guinea pig B cells by one of two distinct Fc gamma receptors on the cells.
    Yamashita T; Koyama J
    J Immunol; 1988 Nov; 141(9):2889-94. PubMed ID: 2971734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of the interaction of monoclonal antibodies with surface IgM on neoplastic B-cells.
    Cragg MS; Zhang L; French RR; Glennie MJ
    Br J Cancer; 1999 Feb; 79(5-6):850-7. PubMed ID: 10070880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surface immunoglobulins are involved in the interaction of protein A with human B cells and in the triggering of B cell proliferation induced by protein A-containing Staphylococcus aureus.
    Romagnani S; Giudizi MG; Biagiotti R; Almerigogna F; Maggi E; Del Prete G; Ricci M
    J Immunol; 1981 Oct; 127(4):1307-13. PubMed ID: 6974188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. B cells from M167 mu kappa transgenic mice fail to proliferate after stimulation with soluble anti-Ig antibodies. A model for antigen-induced B cell anergy.
    Sieckmann DG; Holmes K; Hornbeck P; Martin E; Guelde G; Bondada S; Longo DL; Kenny JJ
    J Immunol; 1994 May; 152(10):4873-83. PubMed ID: 8176209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphoma models for B cell activation and tolerance. VI. Reversal of anti-Ig-mediated negative signaling by T cell-derived lymphokines.
    Scott DW; O'Garra A; Warren D; Klaus GG
    J Immunol; 1987 Dec; 139(12):3924-9. PubMed ID: 3500976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cross-linking of B lymphocyte Fc gamma receptors and membrane immunoglobulin inhibits anti-immunoglobulin-induced blastogenesis.
    Phillips NE; Parker DC
    J Immunol; 1984 Feb; 132(2):627-32. PubMed ID: 6228594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation and proliferation signals in mouse B cells. V.A. comparison of the effects of intact (IgG) and F (ab')2 anti-mu or anti-delta antibodies.
    Klaus GG; Bijsterbosch MK; Parkhouse RM
    Immunology; 1985 Apr; 54(4):677-83. PubMed ID: 2984110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymphoma models for B cell activation and tolerance. V. Anti-Ig mediated growth inhibition is reversed by phorbol myristate acetate but does not involve changes in cytosolic free calcium.
    Scott DW; Livnat D; Whitin J; Dillon SB; Snyderman R; Pennell CA
    J Mol Cell Immunol; 1987; 3(2):109-20. PubMed ID: 3509921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cross-linking of membrane IgM on B CLL cells: dissociation between intracellular free Ca2+ mobilization and cell proliferation.
    Hivroz C; Grillot-Courvalin C; Labaume S; Miglierina R; Brouet JC
    Eur J Immunol; 1988 Nov; 18(11):1811-7. PubMed ID: 3144454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. B cell tolerance induction by cross-linking of membrane IgM, but not IgD, and synergy by cross-linking of both isotypes.
    Gaur A; Yao XR; Scott DW
    J Immunol; 1993 Mar; 150(5):1663-9. PubMed ID: 8436810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of anti-IgM-induced B cell apoptosis by Bcl-xL and CD40 in WEHI-231 cells. Dissociation from cell cycle arrest and dependence on the avidity of the antibody-IgM receptor interaction.
    Merino R; Grillot DA; Simonian PL; Muthukkumar S; Fanslow WC; Bondada S; Núñez G
    J Immunol; 1995 Oct; 155(8):3830-8. PubMed ID: 7561089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphoma models for B cell activation and tolerance. I. Conditions for the anti-mu-dependent stimulation of growth in NBL, a nude B cell lymphoma.
    Ling M; Livnat D; Pillai PS; Scott DW
    J Immunol; 1985 Mar; 134(3):1449-54. PubMed ID: 2578509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of clonal abortion tolerogenesis. II. Clonal behaviour of immature B cells following exposure to anti-mu chain antibody.
    Nossal GJ; Pike BL; Battye FL
    Immunology; 1979 May; 37(1):203-15. PubMed ID: 112040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-4 (B cell stimulatory factor 1) overcomes Fc gamma receptor-mediated inhibition of mouse B lymphocyte proliferation without affecting inhibition of c-myc mRNA induction.
    Phillips NE; Gravel KA; Tumas K; Parker DC
    J Immunol; 1988 Dec; 141(12):4243-9. PubMed ID: 2974056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soluble anti-mu monoclonal antibodies prime resting B cells to secrete immunoglobulins in response to interleukins-4 and -5.
    Phillips C; Klaus GG
    Eur J Immunol; 1992 Jun; 22(6):1541-5. PubMed ID: 1601040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cross-linking of CD23 antigen by its natural ligand (IgE) or by anti-CD23 antibody prevents B lymphocyte proliferation and differentiation.
    Luo HY; Hofstetter H; Banchereau J; Delespesse G
    J Immunol; 1991 Apr; 146(7):2122-9. PubMed ID: 1826018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.